Tianjin State Key Laboratory of Modern Chinese Medicine, 312 Anshanxi Road, Nankai District, Tianjin 300193, China.
J Ethnopharmacol. 2012 Aug 30;143(1):41-8. doi: 10.1016/j.jep.2012.05.052. Epub 2012 Jun 26.
Jinqi formula is a traditional Chinese anti-diabetic formula containing three ingredients (Coptidis rhizoma, Astragali rhadix and Lonicerae japonicae Flos).
The active fractions of Jinqi formula were purified and HPLC analyses were used for quality control. The anti-adipogenic effects of Jinqi formula were analyzed in vitro using 3T3-L1 cells and in vivo with KK-A(y) mice. RT-PCR and Western blot were used to confirm genes and proteins of interest, respectively.
In vitro study showed that Jinqi formula suppressed the accumulation of triglyceride (TG) and free fatty acids (FFA) in mature 3T3-L1 cells by increasing the expression and tyrosine phosphorylation of 5'-AMP-activated protein kinase (AMPK), as well as decreasing the expression of Acetyl CoA Carboxylase (ACC), Fatty Acid Synthase (FAS) and Hormone Sensitive Lipase (HSL). In vivo study demonstrated that Jinqi formula reduced body weight without changing food intake in KK-A(y) mice, and decreased the levels of serum glucose, TG, FFA. In addition, consistent with the in vitro study results, Jinqi formula increased the expression and tyrosine phosphorylation of AMPK in the liver and muscular tissues of the KK-A(y) mice. Furthermore, Jingqi formula suppressed the expression of ACC and HSL and upregulated the expression of IRS-1 in the liver. Whereas in the skeletal muscles, Jingqi formula decreased the expression of ACC and increased the expression of GLUT-4 and IRS-2.
Jingqi formula inhibits TG accumulation at least in part via the stimulation of AMPK activity in a multi-target manner.
金芪降糖配方是一种含三种成分(黄连、黄芪和金银花)的传统中药降糖配方。
金芪降糖配方的活性成分被分离纯化,并通过高效液相色谱法进行质量控制。采用 3T3-L1 细胞进行体外实验,采用 KK-A(y) 小鼠进行体内实验,分析金芪降糖配方的抗脂肪生成作用。采用 RT-PCR 和 Western blot 分别检测目的基因和蛋白。
体外研究表明,金芪降糖配方通过增加 5'-AMP 激活蛋白激酶(AMPK)的表达和酪氨酸磷酸化,以及降低乙酰辅酶 A 羧化酶(ACC)、脂肪酸合成酶(FAS)和激素敏感脂肪酶(HSL)的表达,抑制成熟 3T3-L1 细胞中甘油三酯(TG)和游离脂肪酸(FFA)的积累。体内研究表明,金芪降糖配方在不改变 KK-A(y) 小鼠食物摄入量的情况下降低体重,并降低血清葡萄糖、TG 和 FFA 水平。此外,与体外研究结果一致,金芪降糖配方增加了 KK-A(y) 小鼠肝脏和肌肉组织中 AMPK 的表达和酪氨酸磷酸化。此外,金芪降糖配方抑制了肝脏中 ACC 和 HSL 的表达,上调了 IRS-1 的表达。而在骨骼肌中,金芪降糖配方降低了 ACC 的表达,增加了 GLUT-4 和 IRS-2 的表达。
金芪降糖配方通过刺激 AMPK 活性以多靶点方式抑制 TG 积累。